| Literature DB >> 32950427 |
Yu Sun1, Yifan Lu1, Jason Saredy2, Xianwei Wang2, Charles Drummer Iv1, Ying Shao1, Fatma Saaoud1, Keman Xu1, Ming Liu1, William Y Yang2, Xiaohua Jiang3, Hong Wang2, Xiaofeng Yang4.
Abstract
Reactive oxygen species (ROS) are critical for the progression of cardiovascular diseases, inflammations and tumors. However, the mechanisms of how ROS sense metabolic stress, regulate metabolic pathways and initiate proliferation, inflammation and cell death responses remain poorly characterized. In this analytic review, we concluded that: 1) Based on different features and functions, eleven types of ROS can be classified into seven functional groups: metabolic stress-sensing, chemical connecting, organelle communication, stress branch-out, inflammasome-activating, dual functions and triple functions ROS. 2) Among the ROS generation systems, mitochondria consume the most amount of oxygen; and nine types of ROS are generated; thus, mitochondrial ROS systems serve as the central hub for connecting ROS with inflammasome activation, trained immunity and immunometabolic pathways. 3) Increased nuclear ROS production significantly promotes cell death in comparison to that in other organelles. Nuclear ROS systems serve as a convergent hub and decision-makers to connect unbearable and alarming metabolic stresses to inflammation and cell death. 4) Balanced ROS levels indicate physiological homeostasis of various metabolic processes in subcellular organelles and cytosol, while imbalanced ROS levels present alarms for pathological organelle stresses in metabolic processes. Based on these analyses, we propose a working model that ROS systems are a new integrated network for sensing homeostasis and alarming stress in metabolic processes in various subcellular organelles. Our model provides novel insights on the roles of the ROS systems in bridging metabolic stress to inflammation, cell death and tumorigenesis; and provide novel therapeutic targets for treating those diseases. (Word count: 246).Entities:
Keywords: A sensing network for metabolic stress; Inflammation; Nuclear signaling; Reactive oxygen species (ROS); Trained immunity
Mesh:
Substances:
Year: 2020 PMID: 32950427 PMCID: PMC7767745 DOI: 10.1016/j.redox.2020.101696
Source DB: PubMed Journal: Redox Biol ISSN: 2213-2317 Impact factor: 11.799
The 41 enzymes which are regulating superoxide and hydrogen peroxide are actively functioned and regulated in metabolic processes.
| Name | Abbreviation | Function |
|---|---|---|
| Aldehyde oxidase | AOX1 | Valine, leucine and isoleucine degradation, Tyrosine metabolism, Tryptophan metabolism, Vitamin B6 metabolism and Nicotinate and nicotinamide metabolism |
| Amine oxidase (flavin- containing) A | AOFA | Deamination of 5-hydroxytryptamine, norepinephrine and epinephrine. |
| Amine oxidase (flavin- containing) B | AOFB | Deamination of benzylamine and phenylethylamine |
| OXDA | Regulate the level of neuromodulator | |
| OXLA | Lysosomal antigen processing and presentation | |
| OXDD | Deamination of | |
| Amiloride- sensitive amino oxidase (copper containing) | AOC1 | Degradation of putrescine, histamine, spermine and spermidine |
| Cytochrome P450 3A4 | CP3A4 | Metabolism of sterols, steroid hormones, retinoids and fatty acids |
| Cytochrome P450 2D6 | CP2D6 | Metabolism of fatty acids, steroid and retinoids |
| Cytochrome P450 2E1 | CP2E1 | Metabolism of saturated fatty acids and xenobiotics |
| Cytochrome P450 4A11 | CP4AB | Metabolism of fatty acids and their oxygenated derivatives (oxylipins) |
| ERO1- like protein- α | ERO1A | Involved in disulfide bond formation in ER and reoxidizes P4HB/PDI |
| ERO1- like protein- β | ERO1B | Involved in disulfide bond formation in ER and reoxidizes P4HB/PDI |
| FAD- linked sulfhydryl oxidase ALR | ALR | Regenerate the redox-active disulfide bonds in CHCHD4/MIA40 |
| Hydroxyacid oxidase 1 | HAOX1 | Active on 2-carbon substrate glycolate and 2-hydroxy fatty acids |
| Hydroxyacid oxidase 2 | HAOX2 | Oxidation of L-alpha-hydroxy acids and L-alpha-amino acids |
| Membrane primary amine oxidase | AOC3 | Semicarbazide-sensitive (SSAO) monoamine oxidase activity |
| Peroxisomal N1- acetylspermine/spermidine oxidase | PAOX | Oxidation of N1-acetylspermine to spermidine and putrescine, and polyamine back-conversion |
| Peroxisomal acyl- CoA oxidase 1 | ACOX1 | Desaturation of acyl-CoAs to 2-trans-enoyl-CoAs |
| Peroxisomal acyl- CoA oxidase 3 | ACOX3 | Oxidizes the CoA-esters of 2-methyl-branched fatty acids |
| Peroxisomal sarcosine oxidase | SOX | Metabolizes sarcosine, |
| Prenylcysteine oxidase 1 | PCYOX | Degradation of prenylated proteins and cleavage of thioether bond of prenyl- |
| Prenylcysteine oxidase- like | PCYXL | Prenlcysteine oxidase activity |
| Protein- lysine 6- oxidase | LYOX | Post-translational oxidative deamination of peptidyl lysine residues and regulate Ras expression |
| Pyridoxine 5′- phosphate oxidase | PNPO | Oxidation of pyridoxine 5′-phosphate and pyridoxamine 5′-phosphate |
| Retina- specific copper amine oxidase | AOC2 | Oxidation of 2-phenylethylamine and tryptamine |
| Spermine oxidase | SMOX | Oxidation of spermine and metabolism of N1-acetylspermine and spermidine |
| Sulfhydryl oxidase 1 | QSOX1 | Oxidation of sulfhydryl groups in peptide and protein thiols |
| Sulfhydryl oxidase 2 | QSOX2 | Oxidation of sulfhydryl groups in peptide and protein thiols |
| Sulfite oxidase, mitochondrial | SUOX | Metabolism of sulfur |
| Xanthine dehydrogenase/oxidase | XDH | Purine degradation; oxidation of hypoxanthine and xanthine |
| NADPH oxidase 1 | NOX1 | Regulate cellular pH and mediate proton currents |
| NADPH oxidase 2 | NOX2 (CY24B) | Regulate cellular pH and mediate proton currents |
| NADPH oxidase 3 | NOX3 | Biogenesis of otoconia/otolith |
| NADPH oxidase 4 | NOX4 | Inhibit phosphatase and regulate KCNK3/TASK-1 patassium channel |
| NADPH oxidase 5 | NOX5 | calcium-dependent proton channel and may regulate redox-dependent processes in lymphocytes and spermatozoa |
| Dual oxidase 1 | DUOX1 | Synthesis thyroid hormone, contribute to thyroid peroxidase/TPO and lactoperoxidase/LPO activity |
| Dual oxidase 2 | DUOX2 | Synthesis thyroid hormone, contribute to thyroid peroxidase/TPO and lactoperoxidase/LPO activity |
| Superoxide dismutase [Cu–Zn] | SOD1 | Form fibrillar aggregates in the absence of intramolecular disulfide bond |
| Superoxide dismutase [Mn], mitochondrial | SOD2 | Transcription of RNA polymerase Ii and release of cytochrome C |
| Extracellular superoxide dismutase [Cu–Zn] | SOD3 | Response to copper ion and hypoxia |
The 41 enzymes are generated from PMID:32231263 [102]. The function of enzymes are collected from Human metabolome database (https://hmdb.ca/) and Uniport database (https://www.uniprot.org/).
Fig. 1Four types of ROS (red box) that are generated by nitrogen and oxygen are communication ROS, which are, connected with different types of ROS systems. NO▪, NO2 ▪, H2O2 and ONOO− have the ability to cross lipid membrane and are classified as communication ROS. Three types of nitrogen-containing ROS are communication ROS.
Abbreviations: O2▪−—superoxide, NO▪—nitric oxide radical, NO2 ▪—nitrogen dioxide, OH▪—hydroxyl radical, ROO▪—peroxyl radical, RO▪— alkoxyl radical, CO3▪-—carbonate radical, H2O2—hydrogen peroxide, ONOO−—peroxynitrite, 1O2—singlet oxygen, HOCl—hypochlorous acid, ONOOCO2 −—nitrocarbonate, MitoETC: Mitochondrial electron transport chain, XO—xanthine oxidase, NOS—nitric oxide synthase, CYP— cytochrome P450, NOX—NADPH oxidase, LOX—lipoxygenase, SOD—superoxide dismutase, MPO—myeloperoxidase, MAO— monoaminoxidase. GPX—glutathione peroxidase, PRDX—peroxiredoxin, CAT—catalase. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Reactive oxygen species (ROS) include seven radical- and four non-radical ROS; the generation enzymes and subcellular locations are presented. Among radical ROS, superoxide and nitric oxide are the dominant radicals which are generated by 10 enzymes and 4 enzymes, respectively. Among non-radical ROS, hydrogen peroxide, singlet oxygen and peroxynitrite are major ROS which are generated by 11 and 8 reactions, respectively.
| Category | Name | Formula | Classification | Generating system | Intracellular organelle | PMID | Ref # |
|---|---|---|---|---|---|---|---|
| Radicals | Superoxide | O2▪− | ROS | Complex I | Mt | [ | |
| Complex II | Mt | [ | |||||
| Complex III | Mt | [ | |||||
| XO | Mt, Px, Cyto | [ | |||||
| eNOS | Golgi, PM | [ | |||||
| iNOS | Px | [ | |||||
| nNOS | SR | [ | |||||
| CYP | ER, Mt | [ | |||||
| NOX | NOX1 (Caveolae), NOX2 (Phagosome, PM), NOX3/5 and Duox1/2 (PM), NOX4 (Mt, ER, Nuc) | [ | |||||
| LOX | Cyto, Nuc | [ | |||||
| Radicals | Nitric oxide | NO▪ | RONS | eNOS | Golgi, PM, Mt | [ | |
| iNOS | Px | [ | |||||
| nNOS | SR | [ | |||||
| XO | Px | [ | |||||
| Radicals | Nitrogen dioxide | NO2▪ | RONS | MPO | Nuc, Cyto, Mt | [ | |
| Radicals | hydroxyl radical | OH▪ | ROS | Fenton reaction | Mt, Cyto, Nuc, Px | [ | |
| Haber-Weiss Reaction | Mt, Cyto | [ | |||||
| Radicals | peroxyl radical | ROO▪ | ROS | LOX | Microsome, Mt, Px, PM | [ | |
| Radicals | alkoxyl radical | RO▪ | ROS | LOX | Microsome, Mt, Px, PM | [ | |
| Radicals | Carbonate radical | CO3▪- | ROS | SOD1 | Px | [ | |
| XO | Px | [ | |||||
| Nonradicals | hydrogen peroxide | H2O2 | ROS | SOD | SOD1 (Cyto, Mt, Nuc, Px), SOD2 (Mt matrix), | [ | |
| MAO | Mt | [ | |||||
| XO | Mt, Px, Cyto | [ | |||||
| p66shc | Cyto, Mt | [ | |||||
| acyl-CoA oxidases | Px | [ | |||||
| urate oxidase | Px | [ | |||||
| Px | [ | ||||||
| Px | [ | ||||||
| Px | [ | ||||||
| Px | [ | ||||||
| polyamine oxidase | Px | [ | |||||
| Nonradicals | peroxynitrite | ONOO− | RONS | – | – | [ | |
| Nonradicals | singlet oxygen | 1O2 | ROS | Photooxygenation | Mt, Cyto | [ | |
| MPO | Cyto | [ | |||||
| LOX | Px | 169247 | [ | ||||
| dioxygenase | Px | 169247 | [ | ||||
| lactoperoxidase | Px | 169247 | [ | ||||
| CYP | ER | [ | |||||
| Cytochrome C | Mt | [ | |||||
| Fenton reaction | Px | [ | |||||
| Nonradicals | hypochlorous acid | HOCl | ROS | MPO | Mt, Cyto, Nuc | [ |
Abbreviations: XO—xanthine oxidase, NOS—nitric oxide synthase, CYP—cytochrome P450, NOX—NADPH oxidase, LOX—lipoxygenase, SOD—superoxide dismutase, eNOS—endothelial NOS, iNOS—inducible NOS, nNOS—neuronal NOS, MPO—myeloperoxidase, MAO—monoaminoxidase, Mt—mitochondria, Px—peroxisome, Cyto-cytosol, PM—plasma membrane, ER--endoplasmic reticulum, Nuc—Nucleus, SR--Sarcoplasmic reticulum, ECM—extracellular matrix.
41 specific generation enzymes for hydrogen peroxide and superoxide are also studied in Suppl. Table 1.
ROS scavengers and subcellular localization are indicated, and the scavengers include enzymatic- and non-enzymatic- scavengers. Among the 11 types of ROS, superoxide, peroxyl radical, carbonate radical, hydrogen peroxide and peroxynitrite can be scavenged by enzymes; and the rest six types of ROS are found to be scavenged by non-enzymatic scavengers but not enzymatic scavengers.
| Formula | Enzymatic scavenger | Localization (enzymatic-scavenger) | PMID | Ref # | Non-enzymatic scavenger | PMID | Ref# |
|---|---|---|---|---|---|---|---|
| O2▪− | SOD | SOD1 (Cyto, Mt, Nuc, Px), SOD2 (Mt matrix), SOD3 (ECM) | [ | Bilirubin | [ | ||
| NO▪ | |||||||
| NO2▪ | Urate | [ | |||||
| Ferrocyanide | [ | ||||||
| OH▪ | Vitamin E | [ | |||||
| Uric acid | [ | ||||||
| NDGA | [ | ||||||
| Carotenoids | [ | ||||||
| NAC | [ | ||||||
| Vitamin C | 9090754 | [ | |||||
| ROO▪ | GPX4/5 | Cyto, Nuc, Mt | [ | Carotenoids | [ | ||
| PRDX1/2/3/4/5 | Cyto, Nuc, Mt, Px | [ | Vitamin E | [ | |||
| Uric acid | [ | ||||||
| RO▪ | Vitamin C | [ | |||||
| Edaravone | [ | ||||||
| CO3▪- | CAT | Px, Mt, Cyto, Nuc | [ | Melatonin | [ | ||
| AMK | [ | ||||||
| H2O2 | CAT | Px, Mt, Cyto, Nuc | [ | Bilirubin | [ | ||
| GPX1/2/3/6/7/8 | Cyto, ECM, Mt, ER | [ | |||||
| PRDX1/2/3/4/5/6 | Cyto, Nuc, Mt, Px | [ | |||||
| ONOO− | GPX | Cyto, ECM | Bilirubin | [ | |||
| PRDX5 | Cyto, Nuc, Mt, Px | [ | Uric acid | 9435251 | [ | ||
| 1O2 | Sodium azide | [ | |||||
| Vitamin E | 9119263 | [ | |||||
| Carotenoids | [ | ||||||
| Edaravone | [ | ||||||
| HOCl | Uric acid | [ | |||||
| Carotenoids | [ | ||||||
| Bilirubin | 2542140 | [ | |||||
| NAC | [ | ||||||
| 5-HT/Serotonin | [ |
Abbreviations: GPX—glutathione peroxidase, PRDX—peroxiredoxin, CAT—catalase, NDGA-- nordihydroguaiaretic acid, AMK-- N1-acetyl-5-methoxykynuramine, NAC-- N-acetylcysteine, 5-HT/Serotonin-- 5-Hydroxytryptamine.
The subcellular organelles of ROS generation and scavenging system are organized as follows. Among the twelve subcellular localizations, mitochondria, peroxisome, plasma membrane, cytosol and nucleus cause more than five types of ROS.
| Organelle | Mt | Px | PM | Cyto | Nuc | Golgi | Caveolae | ER | Phagosome | Microsome | SR | ECM | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| O2▪− | – | – | – | – | – | |||||||||||||||||||
| NO▪ | ||||||||||||||||||||||||
| NO2▪ | ||||||||||||||||||||||||
| OH▪ | ||||||||||||||||||||||||
| ROO▪ | – | – | – | – | ||||||||||||||||||||
| RO▪ | ||||||||||||||||||||||||
| CO3▪ | – | – | – | – | ||||||||||||||||||||
| H2O2 | – | – | – | – | – | – | ||||||||||||||||||
| ONOO− | – | – | – | – | – | |||||||||||||||||||
| 1O2 | ||||||||||||||||||||||||
| HOCl | ||||||||||||||||||||||||
Indicates relative ROS generation enzyme subcellular localization and - indicates relative ROS scavenging enzyme subcellular localization.
MitoSOX Red and Amplex Red are used for mtROS detection in vitro; and mitoB is used for mtROS detection in vivo.
| Category | Method | Reagent | Off-target response | Comment | PMID | Ref # |
|---|---|---|---|---|---|---|
| ROS, RNS | ESR | Specific, sensitive, expensive | [ | |||
| Extracellular O2▪− | Fluorescent probe | HPr+ | Membrane impermeable | [ | ||
| General ROS | Fluorescent probe | DCFH-DA | [ | |||
| General ROS | Fluorescent probe | H2DCF | [ | |||
| General ROS | Fluorescent probe | CM-H2DCFDA | [ | |||
| O2▪− | Fluorescent probe | HE/DHE | OH▪, H2O2, OONO- | Cell permeable, intensity quantifiable, low specificity | [ | |
| O2▪− | Fluorescent probe | DPBF | [ | |||
| O2▪− | Fluorescent probe | 2-(2-Pyridil)-benzothiazoline | [ | |||
| O2▪− | Chemiluminescent probe | L-012 | [ | |||
| O2▪− | Chemiluminescent probe | Lucigenin | ONOO- | Cell permeable, low selectivity/sensitivity | [ | |
| O2▪− | Spectrophotometry | NBT | [ | |||
| O2▪− | Fluorescent probe | cpYFP | [ | |||
| OH▪ | Fluorescent probe | CHD | [ | |||
| OH▪ | Fluorescent probe | 3-CCA | [ | |||
| OH▪ | Fluorescent probe | APF | HOCl | [ | ||
| OH▪ | Fluorescent probe | HPF | HOCl | [ | ||
| OH▪ | Fluorescent probe | FL | [ | |||
| ROO▪ | Fluorescent probe | C11-BODIPY581/591 | HO•, RO•, ONOO− | Lipid peroxidation sensor | [ | |
| ROO▪ | Fluorescent probe | DPPP | Lipid peroxidation sensor | [ | ||
| H2O2 | Histochemical staining | DAB | In Situ imaging of ROS | [ | ||
| H2O2 | Fluorescent probe | DCFH | CO3•−, NO2•, HO• | [ | ||
| H2O2 | Fluorescent probe | HyPer | [ | |||
| ONOO- | Fluorescent probe | DHR | HOCl | [ | ||
| 1O2 | Fluorescent probe | DMA | [ | |||
| 1O2 | Fluorescent probe | DPAX | [ | |||
| 1O2 | Fluorescent probe | DMAX | [ | |||
| HOCl | Fluorescent probe | BODIPY-based | [ | |||
| Mt O2▪− | Fluorescent probe | MitoHE | [ | |||
| Mt O2▪− | Fluorescent probe | MitoSox Red | [ | |||
| Mt H2O2 | MitoB | Analyzed by mass spectrometry ex vivo | [ | |||
| O2▪−, H2O2 | Fluorescent probe | Amplex Red | High sensitivity, low background fluorescence | [ | ||
| O2▪−, H2O2 | Chemiluminescent probe | Luminol | OH▪, ONOO- | [ | ||
| ONOO-, H2O2 | Spectrophotometry | Boronates | [ | |||
| Redox status changes | Fluorescent probe | roGFP | Slow in reaction, non-sensitive, real-time, cell friendly but restriction in receptor cells | [ | ||
| Redox status changes | Fluorescent probe | rxYFPs | [ | |||
| Redox status changes | Fluorescent probe | rxRFP | [ |
ESR: electron spin resonance; DCFH-DA: 2,7-Dichlorodihydrofluorescein diacetate; HDCF: 2′,7′-dichloro-dihydrofluorescein; DHE/HE:dihydroethidium; DPBF: 1,3-Diphenylisobenzofuran; L-012: luminol analogue 8-amino-5-chloro-2,3-dihydro-7-phenylpyrido; NBT: Nitroblue tetrazolium; CHD: 1,3-Cyclohexanedione; 3-CCA: Coumarin, coumarin-3-carboxylic acid; SECCA:N-succinimidyl ester of coumarin-3-carboxylic acid; HPF: 2-[6-(4′-Hydroxy)phenoxy-3H-xanthen-3-on-9-yl]benzoic acid; APF: 2-[6-(4′-amino)phenoxy-3H-xanthen-3-on-9-yl] benzoic acid; FL: Fluorescein; DMA: 9,10-Dimethylanthracene; DPAXs: 9-[2-(3-Carboxy-9,10-diphenyl)anthryl]-6-hydroxy-3H-xanthen-3-ones; DMAX: [2-(3-Carboxy-9,10-dimethyl)anthryl]-6-hydroxy-3H-xanthen-3-one; CM-H2DCFDA: 5-(and 6)-chloromethyl-2′,7′-dichlorohydrofluorescein diacetate; scopoletin: 7-hydroxy-6-methoxy-coumarin; HVA: Homovanillic acid (4-hydroxy-3-methoxy-phenylacetic acid; DHR: Dihydrorhodamine 123; Amplex Red:10-acetyl-3,7-dihydroxyphenoxazineDAB: Diaminobenzidine; C11-BODIPY581/591: 4,4-Difluoro-5-(4-phenyl-1,3-butadienyl)-4-bora-3a,4a-diaza-s-indacene-3-undecanoic acid; DPPP: Diphenyl-1-pyrenylphosphine; mitoHE: mito-hydroethidine; HPr+: hydropropidine.
ROS generation Inhibitors.
| Target | Drug | Cell type | Concentration | PMID | Ref # | |
|---|---|---|---|---|---|---|
| General ROS | NAC | RPE cell | 1 mM | [ | ||
| Epithelial cell | 30 mM | [ | ||||
| Fibroblast | 20 mM | [ | ||||
| INS-1 cell | 0.4 mM | [ | ||||
| PDTC | RPE cell | 50uM | [ | |||
| Vitamin C | Endothelial cell | 10uM | [ | |||
| Vitamin E | Endothelial cell | 10uM | [ | |||
| Tempol | Astrocyte | 3 nM | [ | |||
| MnTBAP | Astrocyte | 50uM | [ | |||
| Mitochondrial ROS | complex I | rotenone | RPE cell | 2.5uM | [ | |
| NIH-3T3 fibroblast | 5uM | [ | ||||
| complex II | TTFA | RPE cell | 10uM | [ | ||
| Atpenin A5 | Cardiomyocyte | 100 nM-1uM | [ | |||
| Malonate | Heart Mt | 25-100uM | [ | |||
| Complex III | Myxothizol | Liver Mt | 0.56 mg/kg | [ | ||
| Antimycin A | hepa1-6,Huh-7 cell | 1ug/ml | [ | |||
| RPE cell | 100 ng/ml | [ | ||||
| Compled IV | Sodium azide | Motoneurone | 2 mM | [ | ||
| ATPase | Oligomycin | [ | ||||
| Non-selective | Mito-Tempo | HAEC | 1 mM | [ | ||
| Non-selective | Mito-Vit-E | HUVEC | 1uM | [ | ||
| NOS | Non-selective | L6 myotube | 1 mM | [ | ||
| nNOS | NOSIP | [ | ||||
| eNOS | NMMA | [ | ||||
| NOX | Non-selective | apocynin | SMC | 50uM | [ | |
| VSMC | 100uM | [ | ||||
| DPI | RPE cell | 5uM | [ | |||
| Endothelial cell | 15uM | [ | ||||
| HT-29 cell | 10uM | [ | ||||
| Fibroblast | 20uM | [ | ||||
| NIH-3T3 fibroblast | 5uM | [ | ||||
| AEBSF | 0.9uM | [ | ||||
| NOX1 | ML171 | SMC | 1uM | [ | ||
| NOX1/4 | GKT136901 | [ | ||||
| LOX | NDGA | Epithelial cell | [ | |||
| NIH-3T3 fibroblast | 10uM | [ | ||||
| MPO | ABAH | [ | ||||
| MAO | Selegiline | Astrocyte | 20uM | [ |
NAC– N-acetyl--cysteine, PDTC– pyrrolidene-dithiocarbamate, MnTBAP– Manganese III tetrakis, TTFA– 2-thenoyltrifluoroacetone,-NAME—N omega-Nitro--arginine methyl ester hydrochloride, NMMA– NG-monomethyl-arginine, NOSIP– nitric oxide synthase interacting protein, DPI– diphenylene iodonium, SEBSF– 4-(2-aminoethyl)-benzenesulfonyl fluoride, NDGA– nordihydroguaiaretic acid, ABAH– 4-aminobenzoic acid hydrazide.
Extra-mitochondrial ROS modulate mtROS production, and two types of mtROS modulate extra-mitochondrial ROS production.
| Category | Triggering ROS | Pivotal proteins | Findings | PMID | Ref # |
|---|---|---|---|---|---|
| Extra-mt ROS induced Mt ROS | O2•- | IMAC | Extra-Mt O2•- induced opening of IMAC which depolarized ΔΨm; O2•- was produced in ETC complex III. | [ | |
| H2O2/NO• | Mt-KATP | Extra-Mt H2O2 activated Mt-KATP via PKC-ε leading to the increase of K+ influx and production of O2•- | [ | ||
| HOCl | ETC enzymes | HOCl–oxLDL leads to Mt ROS generation via decreasing activities of ETC dehydrogenase and reductases | [ | ||
| 1O2/H2O2 | MPTP | Mt ROS was triggered by external ROS (possibly 1O2) and linked to MPTP opening and calcium sparks. | [ | ||
| Mt ROS induced extra-mt ROS | ONOO− | Zinc cluster or BH4 | O2•- reacts with NO• to form ONOO− which causes uncoupling of eNOS via oxidation of zinc cluster or BH4 | [ | |
| Cysteine of XDH | O2•- reacts with NO• to form ONOO− which induces disulfide formation between two cysteines of XDH | [ | |||
| H2O2 | c-Src | Activation of c-Src by mitochondrial H2O2 can activate cytoplasmic NOX or increasing its mRNA levels, increasing cytosolic O2•- production | [ |
Abbreviation: ΔΨm, Mitochondrial membrane potential; BH4, Tetrahydrobiopterin; c-Src, Proto-oncogene tyrosine-protein kinase Src; eNOS, Endothelial nitric oxide synthase; ETC, Electron transport chain; H2O2, Hydrogen peroxide; HOCl, Hypochlorous acid; IMAC, Inner membrane anion channel; Mt, Mitochondrion; Mt-KATP, Mitochondrial adenosine triphosphate (ATP)-sensitive potassium channel; MPTP, mitochondrial permeability transition pore; NO, Nitric oxide; NOX NADPH oxidase; O2•-, Superoxide radical anion; 1O2, Singlet oxygen; ONOO−, Peroxynitrite; oxLDL, Oxidized low-density lipoprotein; PKC-ε, Protein kinase C-epsilon; ROS, Reactive oxygen species; XDH, xanthine dehydrogenase.
Fig. 2A. Left panel (a): ROS induces ten types of cell functions (yellow) via various specific downstream pathways (grey). The ten cell functions include: 1) physiological signaling, 2) proliferation, 3) gene regulation, 4) cell cycle regulation, 5) epigenetic modification, 6) post-translational modification, 7) inflammation/innate immunity, 8) pyroptosis, 9) apoptosis, and 10) senescence. Right panel (b): The circus plot indicates that four major ROS generating and anti-ROS regulatory systems have both shared genes and unique genes. On the outside, each arc represents the identity of each gene list。On the inside, each arc represent a gene list, where each gene has a spot on the arc. Dark orange color represents the genes that appear in multiple lists and light orange color represents genes that are unique to that gene list. Purple lines link the same gene that are shared by multiple gene lists. Blue lines link the different genes where they fall into the same ontology them. (also see the detailed information in a supplemental table). Detailed information of Fig. 2A-b see supplemental Table 4.
Abbreviations: IRS1—insulin receptor substrate 1, DRP--dynamin-related protein, OPA1--optic atrophy 1, PTM—post-translational modification, H3K14Ac—histone 3 lysine 14 acetylation, PI3K--phosphatidylinositol-3-kinase, Akt--protein kinase B, mTOR--mammalian target of rapamycin, Ras—GTPase, MEK--MAPK kinase, ERK--extracellular signals-regulated kinase, NF-kB--nuclear factor kappa-lightchain- enhancer of activated B cells, MAPK-- mitogen-activated protein kinases, JNK-- MAPK-Jun N-terminal kinase, Nrf-- Nuclear factor erythroid2-related factor, CDK5--cyclin dependent kinase 5, CKD2-- cyclin dependent kinase 2, NLRP3-- NOD-, LRR- and pyrin domain containing protein 3, GSDMD—gasdermin D, SOD-- superoxide dismutase, LOX--lipoxygenase, NOX--NADPH oxidase. B. The ladder indicates different levels of ROS contribute to different cellular functions. In redox homeostasis state, ROS contributes to physiological signaling. Low ROS increase contributes to proliferation and angiogenesis. Moderated ROS increase contributes to inflammatory response and innate immunity. High ROS increase contributes to various types of cell death. C. Seven types of stimulations promote ROS production, including cytokines, growth factors, hormone/neurotransmitters, hypoxia, high glucose, DAMPs and extracellular ROS.
Abbreviations: TNF-α--tumor necrosis factor- α, IFN-γ-- interferon gamma, IL-1--interleukin 1, IL-2--interleukin 2, IL-4--interleukin 4, IL-13-- interleukin 13, IL-27--interleukin 27, IL-10--interleukin 10, IL-35--interleukin 35, EGF-- epidermal growth factor, PDGF--Platelet derived growth factor, VEGF-- vascular endothelial growth factor, IGF-1--Insulin-like growth factor 1, NE—Norepinephrine, AngII—angiotensin II, AGE-- AGEsadvanced glycation end products, AOPP-- advanced oxidation protein products, ATP-- adenosine triphosphate, LPS—lipopolysaccharide, HS-- Hemodynamic strain, PS-- Pulmonary stretch.
The targets in various treatments in Figure 4 (MitoETC and membrane potential, NOX, SOD and LOX) and genes of their downstream pathways are analyzed by circus plot (see details in Fig. 2A and b).
| Target | Mitochondria ETC and membrane potential | NOX | SOD | LOX |
|---|---|---|---|---|
| Downstream signaling genes | ROMO1 | CDK5 | MAPK3 | PTK2 |
| BCL2L1 | MAPK1 | MAPK1 | PLA2G4A | |
| CASP3 | MAPK2 | |||
| CASP8 | MAPK3 | |||
| NFKB1 | NOS3 | |||
| MAPK1 | PIK3CB | |||
| MAPK2 | AKT1 | |||
| MAPK3 | HMOX1 | |||
| RAC1 | NFKB1 | |||
| AKAP1 | MMP2 | |||
| UTRN | MMP9 | |||
| OPA1 | PRRT2 | |||
| NLRP3 | CDKN2A | |||
| PYCARD | IRS1 | |||
| CASP1 | NFE2L2 | |||
| NOS2 | ||||
| MAP1LC3A | ||||
| PTK2 | ||||
| STAT3 | ||||
| VEGFA | ||||
| MAPK3 | ||||
| MAPK1 | ||||
| CTNNB1 | ||||
| CDK2 | ||||
| MAPK8 | ||||
| MAP2K7 | ||||
| VCAM1 | ||||
Extracellular ROS induce intracellular ROS generation and promote different signaling and functions.
| ROS | Target | Concentration | Function | PMID | Ref # | |
|---|---|---|---|---|---|---|
| ONOO- | Increase | 100uM | Angiogenesis | [ | ||
| Increase | Apoptosis | 9020024 | [ | |||
| H2O2 | Increase | 1-4uM | Insulin secretion | [ | ||
| Increase | NOX4 | 10 uM | Proliferation, Migration | [ | ||
| Increase | 10-20uM | Proliferation | [ | |||
| Increase | Cyto/Nuc ROS | 50uM | Nuclear Calcium signaling | [ | ||
| Increase | 100uM | [ | ||||
| Increase | 200uM | Apoptosis | [ | |||
| Increase | 300uM | Tumor progression | [ | |||
| Increase | 1 mM | Caspase-independent apoptosis | [ |
Eight cytokines, four growth factors, three out of four hormone/neurotransmitters promote ROS production, and anti-inflammatory cytokines IL-10 and Il-35 inhibit ROS production. IGF-1, NE and Dopamin also decrease ROS production in certain condition.
| ROS | Sensor | Target | Concentration | Function | PMID | Ref# | ||
|---|---|---|---|---|---|---|---|---|
| Cytokine | TNF-α | Increase | TNFR | 5-lipoxygenase | 10 ng/ml | Inflammation | [ | |
| Increase | TNFR1 | Complex II, ΔΨm | 20 ng/ml | Inflammation, Apoptosis | [ | |||
| IFN-γ | Increase | IFN-γR | Complex II/NOX | 20 U/ml | Inflammation | [ | ||
| Increase | IFN-γR | Duox2 | 100 U/mL | Innate immunity | [ | |||
| TGF-β | Increase | TGFBR | NOX, Complex I | 10 ng/ml | Fibronectin secretion/EMT | [ | ||
| Increase | TGFBR | NOX4 | 50 ng/ml | Angiogenesis | [ | |||
| IL-1 | Increase | IL1R | 10 ng/ml | Angiogenesis | [ | |||
| Increase | IL1R | NOX | 20 ng/ml | Inflammation | [ | |||
| IL-2 | Increase | IL2R | 100 U/ml | Angiogenesis | [ | |||
| IL-4 | Increase | IL4R | Duox1 | 10 ng/ml | Inflammation, Innate immunity | [ | ||
| IL-13 | Increase | IL13R | Duox1 | 10 ng/ml | Innate immunity | [ | ||
| Increase | IL13R | NOX | 1 μg/μl | Cell death/damage | [ | |||
| IL-27 | Enhance | IL27R | NOX2 | 100 ng/ml | Inflammation | [ | ||
| IL-10 | Decrease | IL10R | 10 ng/ml | Inhibit endothelial cell activation | [ | |||
| IL-35 | Decrease | IL12R/IL27R | Mt | 10 ng/ml | Inhibit endothelial cell activation | [ | ||
| Growth factor | EGF | Increase | EGFR | 5 ng/ml | Adhesion, Migration, Proliferation | [ | ||
| Increase | EGFR | NOX | 10 ng/ml | Proliferation | [ | |||
| Increase | EGFR | 40 ng/ml | Angiogenesis | [ | ||||
| Increase | EGFR | 100 ng/ml | Necrosis | [ | ||||
| PDGF | Increase | PDGFR | 1 ng/ml | Proliferation | [ | |||
| Increase | PDGFR | 15 ng/ml | Senescence | [ | ||||
| Increase | PDGFR | 20 ng/ml | Inflammation | [ | ||||
| VEGF | Increase | VEGFR | mtROS | 50 ng/ml | Migration | [ | ||
| IGF-I | Decrease | IGF-1R | 100 ng/ml | Survival | [ | |||
| Increase | IGF-1R | NOX4 | 200 ng/ml | Migration | [ | |||
| Hormone/Neurotransmitter | NE | Decrease | 10uM | Protect DNA damage | [ | |||
| Insulin | Enhanced | IR | 10–100 nM | Enhance insulin sensitivity | [ | |||
| Dopamine | Increase | MAO | 0-50uM | Physiological signaling | [ | |||
| Increase | mtROS (SOD) | 1uM | Physiological signaling | [ | ||||
| Increase | MAO | 100μM, 500uM | Cell death | [ | ||||
| Decrease | D5R | NOX | Protect from hypertension | [ | ||||
| Serotonin | Increase | 5-HT1BR | NOX1 | 1uM | Post-translational oxidative modification of protein, proliferation | [ | ||
| 10-100uM | Caspase-3 dependent apoptosis | – | ||||||
| AngII | Increase | AT1R | NOX4 (Nuc/Cyto) | 1 nM | Gene regulation, Protect from cell damage | [ | ||
| Increase | AT1R | NOX | 100 nM | maintain arterial tone | [ | |||
| Increase | ET-1AR | NOX | 100 nM | Proliferation | [ | |||
| Increase | AT1/2R | NOX | 100 nM | Apoptosis, Necrosis, Senescence | [ | |||
| Increase | AT1R | NOX | 1uM | Impair insulin signaling | [ |
Hypoxia, hyperglycemia and eighteen types of DAMPs promote ROS production, and hypoxia can also decrease ROS generation in certain conditions.
| ROS | Sensor | Target | Concentration | Function | PMID | Ref # | ||
|---|---|---|---|---|---|---|---|---|
| Hypoxia | Increase | NOX4 | 1% O2 | Angiogenesis, Migration | [ | |||
| Increase | SOD | 5% O2 | Proliferation | [ | ||||
| Decrease | 1% O2 | Protect from apoptosis | [ | |||||
| Hyperglycemia | High glucose | Increase | GLUT | H2O2 | 20 mM | Insulin secretion | [ | |
| Increase | GLUT | NOX | 33 mM | Angiogenesis | [ | |||
| DAMPs | LPA | Increase | Edg | NOX | 10 nM | Proliferation | [ | |
| Increase | LPAR5 | 1uM | pro-inflammatory cytokine and chemokine | [ | ||||
| LPC | Increase | mtROS | 40uM | Trained immunity | [ | |||
| AGEs | Increase | RAGE | 300μg/ml | Cytokine secretion, Caspase-dependent apoptosis | [ | |||
| Increase | Galectin-3, CD36, SR-AI and RAGE | NOX | 400μg/ml | Liver fibrosis | [ | |||
| AOPPs | Increase | NOX4 | 50uM | Cytokine secretion | [ | |||
| Increase | NOX1/4 | 150uM | S-phase arrest | [ | ||||
| Increase | RAGE | NOX2 | 50μg/ml | Apoptosis | [ | |||
| Increase | 200μg/ml | Apoptosis | [ | |||||
| HSA | Increase | 10 mg/ml | Cell death | [ | ||||
| Fatty acid | Increase | Mt | Mitochondrial fission | [ | ||||
| eATP | Increase | P2X7 | 130uM | Cell death | [ | |||
| Increase | DORN1 | NOX | 200uM | Bacterial defense | [ | |||
| Zymosan | Increase | TLR2 | NOX | [ | ||||
| Concanavalin A | Increase | TLR2/4/9 | NOX | [ | ||||
| dsDNA (NCS) | Increase | NOX1 | 0.5ug/ml | Apoptosis | [ | |||
| Thrombin | Increase | GPIbα, PAR4 | FAK/NOX1 | 1–2U/ml | [ | |||
| Increase | NOX | 20U/4ul | Neurodegeneration | [ | ||||
| Integrin | Increase | PRR (β2 integrin Mac-1) | NOX2 | Innate immunity (Phagocytosis) | [ | |||
| Increase | RTKR | LOX, NOX | Cell adhesion | [ | ||||
| ET-1 | Increase | ET1R | eNOS | 1 nM | Nuclear Calcium homoeostasis | [ | ||
| Increase | ET1R | NOX | 10 nM | Protein synthesis | [ | |||
| Increase | ETAR | NOX | Cardiac hypertrophy | [ | ||||
| Methionine | Increase | Mt | [ | |||||
| Homocysteine | Increase | Mt | 500uM | Caspase-1 inflammation activation | [ | |||
| PAMPs | RSV | Increase | TLR2 | Cytokine secretion | [ | |||
| DENV | Increase | TLR9 | Mt | Innate immunity | [ | |||
| Shiga toxin | Increase | CD77 | Caspase-4/GSDMD | 200 ng/ml | Pyroptosis | [ | ||
| LPS | Increase | CD14/TLR4 | Caspase-5 | 10 ng/ml | Inflammation | [ | ||
| Increase | TLR4 | NOX | 10μg/ml | Monocyte adhesion | [ | |||
| Biophysical forces | Hemodynamic strain | Increase | N/A | N/A | Average strain (12%) | Adhesion molecule expression, Monocyte adhesion | 9449403, | [ |
| Increase | Integrins | Mito complex I | Uniaxial cyclic stretch (20%) | Membrane spreading | [ | |||
| Pulmonary strech | Increase | Integrin, EC receptor and ion channel | NOX, XO, eNOS | N/A | Pulmonary hypertension and lung injury | [ |
Abbreviations: EGF-Epidermal growth factor; PDGF-platelet-derived growth factor; VEGF-vesicular epithelial growth factor; IGF-I-insulin-like growth factor; LPA-lysophosphatidic acid; LPC--lysophosphatidylcholine; LPS-lipopolysaccharide; AGEs-advanced glycation end products; AOPPs-advanced oxidation protein products; HAS-human serum albumin; eATP-extracellular ATP; RSV-respiratory syncytial virus; DENV-dengue RNA virus; dsDNA-double-stranded DNA; endothelin-1—ET1; RIRR-ROS-induced ROS release; TBE cell-Tracheobronchial epithelial cells; EC-Endothelial cell; EPC-Endothelial progenitor cell; HCC-hepatocellular carcinoma cell; PPP-pattern recognition receptors; EMT-epithelial mesenchymal transition; ΔΨm, Mitochondrial membrane potential; NE-Norepinephrine; LPC-lysophosphatidylcholine.
Fig. 3A novel working model: 1) ROS are a novel integrated network for sensing homeostasis and alarming stress in organelle- or cytosolic-metabolic stresses; and 2) ROS also serve as cellular communication signaling to increase neighboring cell ROS production.
Abbreviations: O2▪−—superoxide, NO▪—nitric oxide radical, NO2 ▪—nitrogen dioxide, OH▪—hydroxyl radical, ROO▪—peroxyl radical, RO▪— alkoxyl radical, CO3▪-—carbonate radical, H2O2—hydrogen peroxide, ONOO−—peroxynitrite, 1O2—singlet oxygen, HOCl—hypochlorous acid, TCA: tricarboxylic acid cycle.